Alexandria Real Estate Equities, Inc. (NYSE:ARE) is among the 11 Most Oversold S&P 500 Stocks Heading into 2026. On December 5, BofA analyst Joshua Dennerlein slashed his price target on the stock to $50 from $57, while maintaining a Neutral rating on its shares.
The adjustment followed the company’s investor day held during the week. According to TheFly, the analyst said that the management now has a 4-5 year timeline for the life science market to reach equilibrium, up from an earlier expectation of 2-3 years.
Moreover, Dennerlein noted that the company had reduced its FY26 guidance issued at the end of the third quarter.
Earlier, on December 4, BMO Capital trimmed its price target for Alexandria Real Estate Equities, Inc. (NYSE:ARE) to $60 from $67 and kept an Outperform rating for the shares. The firm cited the recent quarterly dividend cut and the lowering of earnings guidance for next year as the reasons for the adjustment.
Last week, the company declared a quarterly cash dividend of $0.72 per common share for Q4 2025, representing a 45% sequential decline, in an effort to further strengthen its balance sheet and liquidity position.
As of the close of business on December 10, Wall Street analysts have a cautious outlook on the stock with a consensus Hold rating. However, Alexandria’s one-year average share price target of $63.08 implies a 36% upside.
Alexandria Real Estate Equities, Inc. (NYSE:ARE) is a life sciences real estate investment trust. The stock has declined 4% over the past week, taking its year-to-date fall to over 52%.
While we acknowledge the potential of ARE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: Top 15 Lowest P/E Ratios of the S&P 500 in 2025 and 10 Best Drone Stocks to Buy Right Now.
Disclosure: None.
